Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Medical Technology Collaboration

21 Feb 2018 07:00

RNS Number : 4572F
Versarien PLC
21 February 2018
 

Versarien plc

("Versarien" or the "Company")

Medical Technology Collaboration

 

Versarien plc (AIM: VRS), the advanced materials engineering group, is pleased to announce that it has signed an agreement to develop a range of graphene based sensor technologies to enable the creation of digital bandages and wound dressings capable of various forms of physiological movement and excretion detection.

This project will utilise strain sensors printed with graphene ink using methods which have been developed by the Company's subsidiary, Cambridge Graphene Limited. Trials will take place at the internationally renowned Addenbrooke's Hospital in Cambridge with Orthopaedic surgeon Dr Arman Memanzedah leading the clinical trials. He will be joined by Dr Simon Rudland from Stowhealth who will be working with the team to optimise the usability of the data from the graphene dressings to ensure the optimal recovery of the patients post discharge. The agreement will also involve Dr Chris Crockford, Managing Director of Digital and Future Technologies Limited, who will act as liaison between the hospital, Versarien and wider global providers in this field.

Neill Ricketts, CEO of Versarien, commented: "We are very pleased to be working to bring our graphene ink technology to the medical arena. This is our first collaboration in this area and we anticipate that the properties of the high quality graphene we produce can bring significant benefits. In particular, the incorporation of graphene inks will enable the development of 'smart' wound dressings, facilitating better patient monitoring and enhanced recovery.

"We are very excited about the potential for graphene in a variety of medical uses and anticipate entering into further collaborations in this area in due course."

 

Enquiries:

Versarien 01242 269 122

Neill Ricketts, CEO

Chris Leigh, CFO

WH Ireland (Nominated Advisor) 0117 945 3470

Mike Coe

Ed Allsopp

IFC Advisory (Financial PR and IR) 0203 934 6630

Tim Metcalfe

Graham Herring

Heather Armstrong

 

About Versarien

Versarien plc (AIM:VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries. Versarien has five subsidiaries operating under two divisions:

Graphene and Plastics

2-DTech Ltd, which specialises in the supply, characterisation and early stage development of graphene products. www.2-dtech.com

ACC Cyroma Ltd, which specialises in the supply of vacuum-formed and injection-moulded products to the automotive, construction, utilities and retail industry sectors. Using Versarien's existing graphene manufacturing capabilities, AAC will have the ability to produce graphene-enhanced plastic products. www.aaccyroma.co.uk  

Cambridge Graphene Ltd, which supplies novel inks based on graphene and related materials, using patented processes and develops graphene materials technology for licensing to manufacturers. www.cambridgegraphene.com 

Thermal and Hard Wear Products

Versarien Technologies Ltd. which owns the exclusive rights to a patent-protected additive process for creating advanced micro-porous metals targeting the thermal management industry and manufactures extruded aluminium heat sinks for the electronics and computing industries. www.versarien-technologies.co.uk 

Total Carbide Ltd, a leading manufacturer in sintered tungsten carbide for applications in arduous environments such as the oil and gas industry. www.totalcarbide.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABBLLLVLFEBBQ
Date   Source Headline
15th Jan 20187:00 amRNSPlanned Chinese graphene manufacturing facility
8th Jan 20187:00 amRNSAgreement with Global Apparel Manufacturer
5th Jan 201811:05 amRNSDirector/PDMR Shareholding
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
7th Dec 20177:00 amRNSExercise of Options
4th Dec 201711:05 amRNSSecond Price Monitoring Extn
4th Dec 201711:00 amRNSPrice Monitoring Extension
4th Dec 20179:00 amRNSPrice Monitoring Extension
4th Dec 20177:00 amRNSAgreement with Global Chemical Major
1st Dec 20172:05 pmRNSSecond Price Monitoring Extn
1st Dec 20172:00 pmRNSPrice Monitoring Extension
29th Nov 20177:00 amRNSInterim Results
28th Nov 20172:05 pmRNSSecond Price Monitoring Extn
28th Nov 20172:00 pmRNSPrice Monitoring Extension
21st Nov 20179:05 amRNSSecond Price Monitoring Extn
21st Nov 20179:00 amRNSPrice Monitoring Extension
17th Nov 20177:00 amRNSCollaboration with Global Consumer Goods Company
7th Nov 20174:40 pmRNSSecond Price Monitoring Extn
7th Nov 20174:35 pmRNSPrice Monitoring Extension
7th Nov 20173:07 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSSuccessful Fundraising of £2.9 million
3rd Nov 20174:43 pmRNSFundraising of approximately £1.2 million
3rd Nov 20174:40 pmRNSTrading Update and Notice of Results
31st Oct 20174:40 pmRNSSecond Price Monitoring Extn
31st Oct 20174:35 pmRNSPrice Monitoring Extension
31st Oct 20172:05 pmRNSSecond Price Monitoring Extn
31st Oct 20172:00 pmRNSPrice Monitoring Extension
31st Oct 20177:00 amRNSCollaboration with Israel Aerospace Industries
2nd Oct 20177:00 amRNSAward of Share Options to Directors
22nd Sep 20171:11 pmRNSDirector/PDMR Shareholding
21st Sep 20179:38 amRNSHolding(s) in Company
20th Sep 20179:00 amRNSHolding(s) in Company
19th Sep 201711:01 amRNSHolding(s) in Company
19th Sep 201711:00 amRNSHolding(s) in Company
19th Sep 20177:00 amRNSSignificant Tender Win
14th Sep 20176:03 pmRNSHolding(s) in Company
13th Sep 201711:45 amRNSResult of AGM
12th Sep 201712:26 pmRNSHolding(s) in Company
12th Sep 20177:00 amRNSHolding(s) in Company
11th Sep 20178:09 amRNSHolding(s) in Company
7th Sep 20177:00 amRNSContract Win
1st Sep 20177:00 amRNSHolding(s) in Company
23rd Aug 20173:45 pmRNSHolding(s) in Company
9th Aug 201710:30 amRNSNotice of AGM
3rd Jul 20177:00 amRNSFinal Results for the year ended 31 March 2017
20th Apr 20177:00 amRNSInvestor Event
20th Apr 20177:00 amRNSResignation of Director
6th Apr 201711:13 amRNSHolding(s) in Company
4th Apr 20173:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.